Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies.

Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies.

Item
http://www.wikidata.org/entity/Q33762423
Beyond taxanes: the next generation of microtubule-targeting agentsA meta-analysis of combination therapy versus single-agent therapy in anthracycline- and taxane-pretreated metastatic breast cancer: results from nine randomized Phase III trials.Overall survival as the outcome for randomized clinical trials with effective subsequent therapiesTriple-negative and basal-like breast cancer: implications for oncologists.CCR 20th anniversary commentary: BMS-247550—microtubule stabilization as successful targeted therapyChemotherapy in Patients with Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer: An Overview.5-FU and ixabepilone modify the microRNA expression profiles in MDA-MB-453 triple-negative breast cancer cellsIxabepilone for the treatment of breast cancer.Antimitotic agents for the treatment of patients with metastatic castrate-resistant prostate cancer.Correlation between rest-activity rhythm and survival in cancer patients experiencing pain.
P2860

Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies.

Item
http://www.wikidata.org/entity/Q33762423
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Ixabepilone plus capecitabine ...... data from 2 phase III studies.
@ast
Ixabepilone plus capecitabine ...... data from 2 phase III studies.
@en
type
label
Ixabepilone plus capecitabine ...... data from 2 phase III studies.
@ast
Ixabepilone plus capecitabine ...... data from 2 phase III studies.
@en
prefLabel
Ixabepilone plus capecitabine ...... data from 2 phase III studies.
@ast
Ixabepilone plus capecitabine ...... data from 2 phase III studies.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P6179
P698
P921
P356
P1433
P1476
Ixabepilone plus capecitabine ...... data from 2 phase III studies.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P6179
P698
P921